Evolent Health, Inc. (EVH) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $54.32M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.10× | Operating cash flow / net income. Period ending 2026-06-30. $54.32M ÷ $-549.88M ≈ -0.10× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 54.32M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 2.10B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -549.88M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $54.32M | (m) | (m) | $2.10B | (m) | $-549.88M | (m) | (m) | (m) | -0.10× |
| 2026-03-31 | (m) | (m) | $33.29M | (m) | (m) | $1.89B | (m) | $-541.41M | (m) | (m) | (m) | -0.06× |
| 2025-12-31 | (m) | (m) | $38.84M | (m) | (m) | $1.88B | (m) | $-534.51M | (m) | (m) | (m) | -0.07× |
| 2025-09-30 | (m) | (m) | $-36.19M | (m) | (m) | $2.05B | (m) | $-128.18M | (m) | (m) | (m) | 0.28× |
| 2025-06-30 | (m) | (m) | $-33.33M | (m) | (m) | $2.20B | (m) | $-130.45M | (m) | (m) | (m) | 0.26× |
| 2025-03-31 | (m) | (m) | $18.42M | (m) | (m) | $2.40B | (m) | $-108.96M | (m) | (m) | (m) | -0.17× |
| 2024-12-31 | (m) | (m) | $18.77M | (m) | (m) | $2.55B | (m) | $-61.62M | (m) | (m) | (m) | -0.30× |
| 2024-09-30 | (m) | (m) | $134.38M | (m) | (m) | $2.46B | (m) | $-72.23M | (m) | (m) | (m) | -1.86× |
| 2024-06-30 | (m) | (m) | $176.23M | (m) | (m) | $2.35B | (m) | $-74.42M | (m) | (m) | (m) | -2.37× |
| 2024-03-31 | (m) | (m) | $155.47M | (m) | (m) | $2.18B | (m) | $-110.34M | (m) | (m) | (m) | -1.41× |
| 2023-12-31 | (m) | (m) | $142.58M | (m) | (m) | $1.96B | (m) | $-113.04M | (m) | (m) | (m) | -1.26× |
| 2023-09-30 | (m) | (m) | $88.90M | (m) | (m) | $1.79B | (m) | $-90.98M | (m) | (m) | (m) | -0.98× |
| 2023-06-30 | (m) | (m) | $24.91M | (m) | (m) | $1.63B | (m) | $-63.53M | (m) | (m) | (m) | -0.39× |
| 2023-03-31 | (m) | (m) | $37.91M | (m) | (m) | $1.48B | (m) | $-40.07M | (m) | (m) | (m) | -0.95× |
| 2022-12-31 | (m) | (m) | $-11.55M | (m) | (m) | $1.35B | (m) | $-19.16M | (m) | (m) | (m) | 0.60× |
| 2022-09-30 | (m) | (m) | $19.41M | (m) | (m) | $1.22B | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $67.38M | (m) | (m) | $1.09B | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $29.47M | (m) | (m) | $989.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $38.75M | (m) | (m) | $907.96M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $-40.76M | (m) | (m) | $931.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $-105.76M | (m) | (m) | $973.64M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $-43.85M | (m) | (m) | $990.22M | (m) | $-265.30M | (m) | (m) | (m) | 0.17× |
| 2020-12-31 | (m) | (m) | $-16.23M | (m) | (m) | $1.02B | (m) | $-334.25M | (m) | (m) | (m) | 0.05× |
| 2020-09-30 | (m) | (m) | $9.81M | (m) | (m) | $987.03M | (m) | $-517.72M | (m) | (m) | (m) | -0.02× |
| 2020-06-30 | (m) | (m) | $13.72M | (m) | (m) | $942.59M | (m) | $-505.89M | (m) | (m) | (m) | -0.03× |
| 2020-03-31 | (m) | (m) | $-37.48M | (m) | (m) | $895.91M | (m) | $-333.98M | (m) | (m) | (m) | 0.11× |
| 2019-12-31 | $-78.18M | (m) | $-42.65M | $35.53M | (m) | $846.38M | (m) | $-301.97M | (m) | (m) | -9.24% | 0.14× |
| 2019-09-30 | $-117.61M | (m) | $-80.80M | $36.81M | (m) | $802.96M | (m) | $-120.56M | (m) | (m) | -14.65% | 0.67× |
| 2019-06-30 | $-78.94M | (m) | $-41.89M | $37.05M | (m) | $732.77M | (m) | $-107.47M | (m) | (m) | -10.77% | 0.39× |
| 2019-03-31 | $-61.11M | (m) | $-21.66M | $39.46M | (m) | $685.11M | (m) | $-85.77M | (m) | (m) | -8.92% | 0.25× |
| 2018-12-31 | $-60.20M | (m) | $-20.65M | $39.55M | (m) | $627.06M | (m) | $-52.66M | (m) | (m) | -9.60% | 0.39× |
| 2018-09-30 | $-25.26M | (m) | $10.35M | $35.62M | (m) | (m) | (m) | $-49.13M | (m) | (m) | (m) | -0.21× |
| 2018-06-30 | $-43.81M | (m) | $-8.15M | $35.66M | (m) | (m) | (m) | $-49.29M | (m) | (m) | (m) | 0.17× |
| 2018-03-31 | $-49.32M | (m) | $-17.90M | $31.42M | (m) | (m) | (m) | $-56.28M | (m) | (m) | (m) | 0.32× |
| 2017-12-31 | $-55.81M | (m) | $-27.96M | $27.85M | (m) | (m) | (m) | $-60.66M | (m) | (m) | (m) | 0.46× |
| 2017-09-30 | $-81.26M | (m) | $-55.50M | $25.76M | (m) | (m) | (m) | $-64.91M | (m) | (m) | (m) | 0.85× |
| 2017-06-30 | $-79.00M | (m) | $-58.30M | $20.70M | (m) | (m) | (m) | $-63.53M | (m) | (m) | (m) | 0.92× |
| 2017-03-31 | $-67.62M | (m) | $-49.47M | $18.15M | (m) | (m) | (m) | $-55.01M | (m) | (m) | (m) | 0.90× |
| 2016-12-31 | $-51.04M | (m) | $-35.51M | $15.53M | (m) | (m) | (m) | $-159.74M | (m) | (m) | (m) | 0.22× |
| 2016-09-30 | $-34.04M | (m) | $-20.32M | $13.72M | (m) | (m) | (m) | $-146.45M | (m) | (m) | (m) | 0.14× |
| 2016-06-30 | $-47.34M | (m) | $-34.58M | $12.76M | (m) | (m) | (m) | $-147.56M | (m) | (m) | (m) | 0.23× |
| 2016-03-31 | $-49.14M | (m) | $-39.27M | $9.87M | (m) | (m) | (m) | $221.00M | (m) | (m) | (m) | -0.18× |
| 2015-12-31 | $-24.98M | (m) | $-18.47M | $6.51M | (m) | (m) | (m) | $332.49M | (m) | (m) | (m) | -0.06× |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $325.92M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $334.73M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-31.12M | (m) | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | $-25.25M | (m) | (m) | (m) | 0.00× |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-24.07M | (m) | $-13.63M | $10.44M | (m) | (m) | (m) | $20.02M | (m) | (m) | (m) | -0.68× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |